Related Experiment Video

Updated: Jun 24, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

Prognostic factors in chronic heart failure. A review of serum biomarkers, metabolic changes, symptoms, and scoring

Mitja Lainscak1, Stefan D Anker

  • 1Division of Cardiology, University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia. mitja.lainscak@guest.arnes.si

Herz
|April 17, 2009
PubMed

Insights

Making treatment decisions for chronic heart failure (CHF) is complex. This review examines routine clinical parameters, like biomarkers and exercise capacity, for risk stratification in CHF patients, though more research is needed.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Biomarkers

Background:

  • Chronic heart failure (CHF) management involves complex decision-making due to numerous therapeutic options with marginal benefits.
  • Accurate risk stratification is crucial for optimizing CHF patient care.
  • There is a need for accessible and clinically valuable parameters beyond sophisticated procedures.

Purpose of the Study:

  • To review the importance and validity of routinely available clinical parameters for risk stratification in chronic heart failure (CHF).
  • To assess the utility of serum biomarkers, metabolic changes, symptom status, exercise capacity, and prognostic scoring systems in CHF management.

Main Methods:

  • Literature review of existing studies on prognostic markers in chronic heart failure.
  • Analysis of the clinical value of serum biomarkers (natriuretic peptides, uric acid, lipoproteins, cytokines).
  • Evaluation of metabolic factors (insulin resistance, BMI), patient-reported symptoms, exercise capacity, and prognostic scoring systems.

Main Results:

  • Routinely available clinical parameters, including serum biomarkers and patient measures, hold potential clinical value for CHF risk stratification.
  • Limited evidence currently supports the use of prognostic markers to improve treatment decisions and patient outcomes in CHF.
  • Further research is required to establish the definitive role of these markers in guiding CHF therapy.

Conclusions:

  • Accessible clinical parameters offer a promising avenue for risk stratification in chronic heart failure (CHF).
  • The current evidence base is insufficient to confirm that using prognostic markers in treatment decisions improves CHF outcomes.
  • Extensive further investigation is necessary to validate and implement these markers effectively in clinical practice for CHF.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...